After Years of Circling the Industry Looking For Signs to Invest, and While Watching the Growing Need for Opioid-Free Mental Health Treatment, Investors Are Now Beginning to See Psychedelics as... read more →
MindMed Plans to Use the Phase 1 Study to Experiment with Dosing Methods to Better Understand How Humans React to Ayahuasca's Active Ingredient, DMT The Phase 1 Clinical Trials Will... read more →
The Federal Government of Both the U.S. and Canada Have Green-Lit the Burgeoning Psychedelics Industry While Also Placing Extremely High Barriers to Entry Strict Regulations Have Prevented Wannabe Firms from... read more →
Welcome to the Cannabis Countdown. In this week’s rendition, we’ll recap and countdown the top 10 Marijuana and Psychedelic Stock News stories for the week of March 23rd – 29th, 2020.... read more →
The Burgeoning Psychedelics Industry Has Investors Tripping For an Opportunity to Ride the Shroom Boom For Those Looking to Enter the Emerging Sector, These 3 Psychedelic Stocks Should Be on... read more →
The Psychedelics Industry is Beginning to Heat Up, Giving Cannabis Investors an Eerie Sense of Déja Vu Psychedelic Stocks Are in High Demand as Champignon Brands and MindMed IPO in... read more →
Psychedelics Firm MindMed Raised $24 Million in Pre IPO Round Which Featured Kevin O'Leary and Bruce Linton Now Listed on the NEO, MMED Stock Was Very Active on its First... read more →
